ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
https://doi.org/10.20996/1819-6446-2007-3-2-43-47
Abstract
Aim. To evaluate the effect of imidasoline agonist, rilmenidine (Albarel), on 24-hour blood pressure (BP) profile and autonomic regulation of cardiovascular system in young patients with arterial hypertension (HT) and exogenous constitutional obesity (ECO).
Material and methods. The study included 80 men aged 18-32 ( average age 20,5 years), including 34 patients with HT and normal body weight, 36 patients with HT and ECO, 10 healthy men as a control group. All hypertensive patients were treated with rilmenidine 1-2 mg daily during 12 weeks. BP 24-hour profile and heart rate variability (HRV) were estimated before and after therapy.
Results. Rilmenidine monotherapy resulted in significant reduction in average 24-hour, day-time and night-time BP as well as indices of BP loading in both groups. Indices of HRV proved the initial sympathetic overdrive among hypertensive patients especially among those with ECO. This sympathetic overdrive significantly reduced after 12 weeks of therapy.
Conclusion. Rilmenidine effectively controls BP and reduces sympathetic system overdrive in young hypertensive patients with ECO.
About the Authors
N. N. NikitinaRussian Federation
Chair of therapy and adolescent medicine
A. G. Avtandilov
Russian Federation
Chair of therapy and adolescent medicine
K. R. Petrosyan
Russian Federation
Chair of therapy and adolescent medicine
S. L. Petrosov
Russian Federation
Chair of therapy and adolescent medicine
References
1. Автандилов А.Г., Александров А.А., Кисляк О.А. и др. Диагностика, лечение и профилактика артериальной гипертензии у детей и подростков. (Методические рекомендации). http://www.cardiosite.ru/medical/recom-diagnoz.asp
2. Баевский Р.М., Иванов Г.Г., Чирейкин Л.В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем. Вестник аритмологии 2001;24:65-86
3. Кобалава Ж.Д., Котовская Ю.В. Суточное мониторирование артериального давления: методические аспекты и клиническое значение. М., 1999, 234 с.
4. Шляхто Е.В., Конради А.О. Причины и последствия активации симпатической нервной системы при артериальной гипертензии. Артериальная гипертензия 2003;9(3):81-7
5. Шляхто Е.В., Конради А.О. АЛЬТАИР – АЛЬбарел: эффективность и переносимость при Артериальной гипертензии. Артериальная гипертензия 2004;10 (3):163-164
6. Grassi G. Role of the sympathetic nervous system in human hypertension. J. Hypertens. 1998;16: 1979-1987
7. De Luca N., Izzo R., Fontana D. et al. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine. J. Hypertens. 2000;18:1515-1522
8. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Task force of the European society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur. Heart J. 1996;17:354-381
9. Luccioni R. Evaluation pharmaco-epidemiologique de la rilmenidine chez 18335 hypertendus. Presse. Med. 1995;24;1857-1864
10. Prichard B., Graham B. I1 imidasoline agonists. General clinical pharmacology of imidasoline receptors: implications for the treatment of the elderly. Drugs Aging 2000;17(2):133-159
Review
For citations:
Nikitina N.N., Avtandilov A.G., Petrosyan K.R., Petrosov S.L. ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY. Rational Pharmacotherapy in Cardiology. 2007;3(2):43-47. (In Russ.) https://doi.org/10.20996/1819-6446-2007-3-2-43-47